Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Fibroblast expression of transmembrane protein smoothened governs microenvironment characteristics after acute kidney injury
Yuan Gui, … , Youhua Liu, Dong Zhou
Yuan Gui, … , Youhua Liu, Dong Zhou
Published May 7, 2024
Citation Information: J Clin Invest. 2024;134(13):e165836. https://doi.org/10.1172/JCI165836.
View: Text | PDF
Research Article Nephrology

Fibroblast expression of transmembrane protein smoothened governs microenvironment characteristics after acute kidney injury

  • Text
  • PDF
Abstract

The smoothened (Smo) receptor facilitates hedgehog signaling between kidney fibroblasts and tubules during acute kidney injury (AKI). Tubule-derived hedgehog is protective in AKI, but the role of fibroblast-selective Smo is unclear. Here, we report that Smo-specific ablation in fibroblasts reduced tubular cell apoptosis and inflammation, enhanced perivascular mesenchymal cell activities, and preserved kidney function after AKI. Global proteomics of these kidneys identified extracellular matrix proteins, and nidogen-1 glycoprotein in particular, as key response markers to AKI. Intriguingly, Smo was bound to nidogen-1 in cells, suggesting that loss of Smo could affect nidogen-1 accessibility. Phosphoproteomics revealed that the ‘AKI protector’ Wnt signaling pathway was activated in these kidneys. Mechanistically, nidogen-1 interacted with integrin β1 to induce Wnt in tubules to mitigate AKI. Altogether, our results support that fibroblast-selective Smo dictates AKI fate through cell-matrix interactions, including nidogen-1, and offers a robust resource and path to further dissect AKI pathogenesis.

Authors

Yuan Gui, Haiyan Fu, Zachary Palanza, Jianling Tao, Yi-Han Lin, Wenjian Min, Yi Qiao, Christopher Bonin, Geneva Hargis, Yuanyuan Wang, Peng Yang, Donald L. Kreutzer, Yanlin Wang, Yansheng Liu, Yanbao Yu, Youhua Liu, Dong Zhou

×

Figure 4

Phosphoproteomics reveals Wnt pathway activation in fibroblast-specific Smo-deletion kidneys after AKI.

Options: View larger image (or click on image) Download as PowerPoint
Phosphoproteomics reveals Wnt pathway activation in fibroblast-specific ...
(A) Workflow of phosphoproteomics. (B) Principal component analysis of phosphoproteins from Gli1-Smo+/+ and Gli1-Smo–/– kidneys 1 day after ischemic AKI. (C) Volcano plot of pairwise comparisons (fold-change, FC) between the kidney phosphoproteomes of Gli1-Smo+/+ and Gli1-Smo–/– kidneys 1 day after ischemic AKI. (D) qPCR of Wnt 1, 2, 4, 5A, 5B, 7A, 7B, 9B, 10A, 10B, 11, and 16 mRNA in Gli1-Smo+/+ and Gli1-Smo–/– kidneys 1 day after ischemic AKI. *P < 0.05 (n = 7–12). (E) Western blots of β-catenin, Wnt 1, and Wnt 5A/B proteins in Gli1-Smo+/+ and Gli1-Smo–/– kidneys 1 day after ischemic AKI. Numbers indicate individual animals in a given group. (F) Western blots of β-catenin and Wnt 1 in Pdgfr-β-Smo+/+ and Pdgfr-β-Smo–/– kidneys 1 day after ischemic AKI. Numbers indicate individual animals in a given group. (G) IHC staining showing β-catenin, Wnt1, Wnt 4, and Wnt5A/B in Gli1-Smo+/+ and Gli1-Smo–/– or in Pdgfr-β-Smo+/+ and Pdgfr-β-Smo–/– kidneys 1 day after ischemic AKI. Scale bar: 25 μm. (H) IHC staining showing Wnt1, Wnt 4, and Wnt5A/B expression in kidney biopsy specimens from patients with AKI. Arrows indicate positive staining. Scale bar: 25 μm. Graphs are presented as means ± SEM. Differences between groups were analyzed using unpaired t tests.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts